Ad
related to: fda approved silica gel for skin problems treatment mayo clinic
Search results
Results From The WOW.Com Content Network
Some additives and gelators added into the formulation may cause irritation problems, [5] [8] such as skin irritation, dermatitis or allergic conditions. [2] The increased water content in gels increases the chances of microbial or fungal attack, [ 5 ] [ 8 ] which may contaminate the gel, making it unsuitable for use.
In the United States, topical alitretinoin is indicated for the treatment of skin lesions in AIDS-related Kaposi's sarcoma. Alitretinoin is not indicated when systemic therapy against Kaposi's sarcoma is required. [2] It has received EMA (11 October 2000) and FDA (2 March 1999) approval for this indication. [3] [4]
Diclofenac, sold under the brand name Voltaren among others, is a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain and inflammatory diseases such as gout. [6] [9] It can be taken orally (swallowed by mouth), inserted rectally as a suppository, injected intramuscularly, injected intravenously, applied to the skin topically, or through eye drops.
Colloidal silica gel with light opalescence. Silica gel is an amorphous and porous form of silicon dioxide (silica), consisting of an irregular tridimensional framework of alternating silicon and oxygen atoms with nanometer-scale voids and pores. The voids may contain water or some other liquids, or may be filled by gas or vacuum.
Adapalene Gel, sold in trade name Differin in China. Adapalene, sold under the brand name Differin among others, is a third-generation topical retinoid primarily used in the treatment of mild-moderate acne, and is also used off-label to treat keratosis pilaris as well as other skin conditions. [6]
(Reuters) -The U.S. Food and Drug Administration has approved Verrica Pharmaceuticals Inc's treatment of a viral skin infection in adults and children aged 2 years and above, the company said on ...
Unlike its previously approved product for small nicks and cuts, the new gel, Traumagel, can be used for life-threatening injuries, CEO and co-founder Joe Landolina told Reuters.
In 2004, 3M obtained FDA approval to market imiquimod as a treatment for superficial basal cell carcinoma. [ 21 ] In 2006, 3M sold its pharmaceutical business in the Americas to Graceway Pharmaceuticals , its European pharmaceutical business to Meda AB , and its pharmaceutical business in other territories to two private equity firms.